Black Rose Industries Reports Q1 Results, Approves Key Management Changes and Subsidiary Divestment
Black Rose Industries reported Q1 FY2026 standalone revenue of ₹59.85 crore and net profit of ₹4.24 crore. The company appointed Ratan Agrawal as Chief Risk Officer and designated Dr. Pavankumar Aduri and Bhavesh Shah as Senior Management Personnel. M/s. Shiv Hari Jalan & Co. were appointed as Secretarial Auditors for 5 years. The Board approved the closure, sale, or transfer of its Japanese subsidiary, B.R. Chemicals Co. Limited, subject to shareholder approval. The 35th AGM is scheduled for September 29, 2025, via video conferencing.

*this image is generated using AI for illustrative purposes only.
Black Rose Industries Limited , a prominent player in the chemicals sector, has announced its financial results for the first quarter ended June 30, 2025, along with several significant corporate decisions. The company's Board of Directors approved these measures during a meeting held on August 14, 2025.
Financial Performance
For the quarter ended June 30, 2025, Black Rose Industries reported standalone revenue from operations of ₹59.85 crore, with a net profit of ₹4.24 crore. The company's performance reflects its continued operations in the chemical industry.
Key Management Changes
The Board has made several important decisions regarding the company's management structure:
Chief Risk Officer Appointment: Mr. Ratan Agrawal, the current Chief Financial Officer, has been appointed as the Chief Risk Officer of the company.
Senior Management Designations: Dr. Pavankumar Aduri, Vice President-Innovation, and Mr. Bhavesh Shah, General Manager-Sales, have been designated as Senior Management Personnel. This move is part of the reorganization of the company's Key Managerial Personnel structure.
Dr. Aduri brings over 16 years of experience in the chemical industry, with a Ph.D. in Chemical Engineering. He has been instrumental in driving innovation across specialty chemicals, polymer additives, liquid formulations, and pigments.
Mr. Shah, with over 30 years of experience, holds a Master's in Management Studies (Finance) from NMIMS and has been associated with the company since 2008, leading critical functions in marketing and sales.
Corporate Governance
The company has taken steps to strengthen its corporate governance:
Secretarial Auditor Appointment: M/s. Shiv Hari Jalan & Co., Practicing Company Secretaries, have been appointed as Secretarial Auditors for a term of 5 years (FY 2025-26 to FY 2029-30), subject to shareholder approval.
Annual General Meeting: The 35th Annual General Meeting is scheduled for September 29, 2025, to be held via video conferencing.
Strategic Business Decision
In a significant move, the Board has approved, subject to shareholder approval, the closure, sale, or transfer of 100% shareholding in its wholly-owned material subsidiary, B.R. Chemicals Co. Limited, Japan. This subsidiary contributed ₹54.37 crore, representing 13.57% of the total consolidated income of the company in the last financial year.
The decision follows the earlier move to discontinue the subsidiary's business operations from January 30, 2025. This strategic step is expected to impact the company's consolidated financial structure, as the subsidiary also contributed 3.67% to the total consolidated net worth.
Black Rose Industries continues to adapt to market conditions and streamline its operations, focusing on its core chemical business in India. The company's actions reflect its commitment to enhancing operational efficiency and shareholder value in the evolving business landscape.
Historical Stock Returns for Black Rose Industries
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-0.29% | +2.04% | +3.83% | +11.37% | -29.42% | -19.84% |